Menu Back toAdvanced Analytics, Cross-Industry Collaboration, and Data Sharing to Change the Paradigm in Clinical Quality

DIA 2021 Global Annual Meeting


Advanced Analytics, Cross-Industry Collaboration, and Data Sharing to Change the Paradigm in Clinical Quality

Session Chair(s)

Timothe Claude Menard, PharmD, MSc

Timothe Claude Menard, PharmD, MSc

  • Head of Quality Data Science
  • F. Hoffmann- La Roche Ltd, Switzerland
In this session, we will share selected use cases on our collaboration framework. We will also engage with the audience on how we (industry, regulators, patients) can all contribute to a change in paradigm for QA, i.e. where advanced analytics can help detecting and mitigating issues faster, and ultimately accelerate approval and patient access of innovative drugs.
Learning Objective : Examine how advanced analytics are utilized throughout the development lifecycle and how this could lead to a paradigm shift in clinical quality; Describe how the inter company quality analytics (IMPALA) group members collaborate to accelerate the development of advanced analytics for clinical quality; Identify how cross-company data sharing can foster development and validation of advanced analytics.

Speaker(s)

Jennifer  Emerson, PhD, MPH, RN, PMP

Industry Update

Jennifer Emerson, PhD, MPH, RN, PMP

  • Head of Audit Excellence
  • Boehringer Ingelheim Pharma GmbH & Co. KG, Germany
David  Donohue, MBA

Industry Update

David Donohue, MBA

  • Head, Quality Systems and Data Analytics
  • GlaxoSmithKline, United States
Robert  Studt

Industry Update

Robert Studt

  • Head of Quality Analytics, BioResearch Quality and Compliance
  • Johnson & Johnson, United States